Firm Analyst Name
Guggenheim Securities
Vamil Divan, MD, MBA
H.C. Wainwright
Oren Livnat
Truist Securities
Leszek Sulewski

ANI Pharmaceuticals, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding ANI Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ANI Pharmaceuticals, Inc. or its management. ANI Pharmaceuticals, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.